Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Medicina (Kaunas) ; 58(10)2022 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-36295581

RESUMO

Background and Objectives: Several treatments are available for sudden sensorineural hearing loss (SSNHL), but no studies have compared the different treatments based on the delay from the onset of the disease. Our study aims to compare the effect of hyperbaric oxygen therapy (HBOT), oral steroids (OS) and combination of both therapies (HBOT + OS) for treating SSNHL. Materials and Methods: This randomized study analyzed 171 patients with SSNHL. Patients were evaluated by pure tone audiometry test (PTA) at baseline (T0) and 20 days after treatment (T1). Three groups were available HBOT-A-, OS-B- and HBOT + OS-C-. After baseline PTA, patients were randomly assigned to each group. Statistical analysis was performed by one-way ANOVA and Chi-square. Results: Patients in the HBOT + OS and HBOT groups improved their auditory function (p < 0.05). HBOT was the best choice for treatment when started by 7 days from SSNHL onset, while HBOT + OS in case of late treatment. Profound SNHL recovered equally by HBOT and HBOT + OS (p < 0.05). Upsloping SNHL obtained better auditory results by HBOT compared to HBOT + OS (p < 0.05). Downsloping and flat SSNHL had the most improvement with HBOT + OS compared to HBOT only (p < 0.05). Conclusions: Combination of HBOT and OS is a valid treatment for SSNHL both in case of early and late treatment. Combination of HBOT and OS was the choice with the best results in case of treatment started >14 days from symptom onset.


Assuntos
Perda Auditiva Neurossensorial , Perda Auditiva Súbita , Oxigenoterapia Hiperbárica , Humanos , Oxigenoterapia Hiperbárica/métodos , Resultado do Tratamento , Perda Auditiva Súbita/tratamento farmacológico , Perda Auditiva Neurossensorial/tratamento farmacológico , Esteroides , Estudos Retrospectivos
2.
Ear Nose Throat J ; 100(5_suppl): 734S-737S, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32088986

RESUMO

Tapia syndrome is a rare complication after surgery, with ipsilateral paralysis of vocal cord and tongue due to extracranial involvement of recurrent laryngeal and hypoglossal nerves. Tapia's case report is extremely interesting for both the rarity of the reported cases and for the importance of an early rehabilitation. In a previous work, we reported a case of Tapia syndrome after cardiac surgery for aortic aneurysm, and the protocol of logopedic rehabilitation adopted. In the postoperative period, he developed severe dyspnea and dysphagia that required a tracheostomy and a logopedic rehabilitation therapy that led to a fast and efficient swallowing without aspiration after 47 sessions (less than 4 months). The progressive recovery of the function suggests aprassic nerve damage. However, the logopedic therapy is recommended to limit the possibility of permanent functional deficits and quickly recover swallowing and phonation.


Assuntos
Terapia Miofuncional/métodos , Paralisia/reabilitação , Tireoidectomia/efeitos adversos , Doenças da Língua/reabilitação , Paralisia das Pregas Vocais/reabilitação , Humanos , Paralisia/etiologia , Complicações Pós-Operatórias/reabilitação , Traumatismos do Nervo Laríngeo Recorrente/complicações , Fonoterapia/métodos , Síndrome , Doenças da Língua/etiologia , Traumatismos do Nervo Vestibulococlear/complicações , Paralisia das Pregas Vocais/etiologia
3.
Eur Arch Otorhinolaryngol ; 277(6): 1847-1848, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31912215

RESUMO

In this letter, we discuss possible alternatives and future perspectives in the therapy of Meniere's disease. Special attention should be paid to the role of dietary restrictions for glucose in patients with Meniere's disease, as there is a strong evidence about the presence of insulin receptors in the saccule, the main structure affected by pathological changes due to endolymphatic hydrops; to the possible use of endogenous antisecretory factor administered in specially processed cereals; and to the effects of low-dose intratympanic gentamicin, especially in patients with intractable Meniere's disease.


Assuntos
Hidropisia Endolinfática , Doença de Meniere , Hidropisia Endolinfática/tratamento farmacológico , Gentamicinas , Humanos , Itália , Doença de Meniere/tratamento farmacológico , Sáculo e Utrículo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...